BCAL Diagnostics (ASX:BDX) Shares Buyback Ratio %: -0.74 (As of Sep. 08, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is BCAL Diagnostics Shares Buyback Ratio %?

BCAL Diagnostics ASX:BDX -2.99% Shares Buyback Ratio % is -0.74 as of Sep. 08, 2026. The stock has 5 warning signs investors should review.

Shares Outstanding (EOP) are shares that have been authorized, issued, and purchased by investors and are held by them.

GuruFocus calculates shares buyback ratio using previous shares outstanding minus the current shares outstanding, and then divides by previous shares outstanding. BCAL Diagnostics's current shares buyback ratio was -0.74%.

BCAL Diagnostics Shares Buyback Ratio % Related Terms

BCAL Diagnostics Shares Buyback Ratio % Historical Data

* Premium members only.

The historical data trend for BCAL Diagnostics's Shares Buyback Ratio % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

BCAL Diagnostics Shares Buyback Ratio % Chart

BCAL Diagnostics Annual Data
Trend Jun22 Jun23 Jun24 Jun25 Jun26
Shares Buyback Ratio %
0.00 -2.35 -48.03 -16.44 -0.74

BCAL Diagnostics Semi-Annual Data
Dec20 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25 Jun26
Shares Buyback Ratio % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only -24.90 -16.44 0.00 -0.57 -0.17

BCAL Diagnostics Shares Buyback Ratio % Calculation

BCAL Diagnostics's Shares Buyback Ratio for the fiscal year that ended in Jun. 2026 is calculated as

Shares Buyback Ratio=(Shares Outstanding (EOP) (A: Jun. 2025 ) - Shares Outstanding (EOP) (A: Jun. 2026 )) / Shares Outstanding (EOP) (A: Jun. 2025 )
=(365.968 - 368.683) / 365.968
=-0.74%

BCAL Diagnostics's Shares Buyback Ratio for the quarter that ended in Jun. 2026 is calculated as

Shares Buyback Ratio=(Shares Outstanding (EOP) (A: Dec. 2025 ) - Shares Outstanding (EOP) (A: Jun. 2026 )) / Shares Outstanding (EOP) (A: Dec. 2025 )
=(368.068 - 368.683) / 368.068
=-0.17%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Shares Buyback Ratio % →
What does a Shares Buyback Ratio % of -0.74 mean?
BCAL Diagnostics (ASX:BDX) has a Shares Buyback Ratio % of -0.74 as of Sep. 08, 2026. Share buyback ratio is the percent change of a company's shares outstanding from two periods. View historical data on BCAL Diagnostics and its competitors.
Is BCAL Diagnostics' Shares Buyback Ratio % too high?
BCAL Diagnostics' current Shares Buyback Ratio % is -0.74.
How does BCAL Diagnostics' Shares Buyback Ratio % compare to TMO and DHR?
BCAL Diagnostics' Shares Buyback Ratio % of -0.74 can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Shares Buyback Ratio % for a Medical Diagnostics & Research company?
A good Shares Buyback Ratio % depends on the Medical Diagnostics & Research industry context. However, Shares Buyback Ratio % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Shares Buyback Ratio % mean?
A high Shares Buyback Ratio % can signal that a stock is expensive relative to its fundamentals. Share buyback ratio is the percent change of a company's shares outstanding from two periods. View historical data on BCAL Diagnostics and its competitors. BCAL Diagnostics's current Shares Buyback Ratio % is -0.74. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BCAL Diagnostics stock overvalued right now?
BCAL Diagnostics (ASX:BDX) has a current Shares Buyback Ratio % of -0.74. The current Shares Buyback Ratio % is -0.74. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Shares Buyback Ratio % calculated?
Shares Buyback Ratio % is calculated from a company's financial statements. For BCAL Diagnostics (ASX:BDX), the current Shares Buyback Ratio % is -0.74 as of Sep. 08, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

BCAL Diagnostics Business Description

Address 50 Clarence Street, Suite 506, Level 5, Sydney, NSW, AUS, 2000
BCAL Diagnostics Ltd is a biotechnology company developing a novel blood screening test to improve the early diagnosis and monitoring of breast cancer that is safe, cost-effective, accurate, and available to all women regardless of age, race, and geographic location.